Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 468 Magnetic Resonance Spectroscopy 362 pembrolizumab 289 Biopsy 253 Carboplatin 237 Cisplatin 199 Cyclophosphamide 192 Paclitaxel 169 Nivolumab 157 Gemcitabine 146 Radiotherapy 131 Bevacizumab 120 Dexamethasone 112 fludarabine 102 Fluorouracil 99 Radiation 98 Docetaxel 97 Pemetrexed 96 Doxorubicin 95 durvalumab 90 Oxaliplatin 89 Rituximab 88 venetoclax 87 atezolizumab 83 Leucovorin 81 Capecitabine 80 Prednisone 74 Lenalidomide 74 Etoposide 73 X-Rays 70

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lysine × 30 days × Clear all

NCT07150806 2026-05-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡